3-Methylglutaconic aciduria type 1
MGCA1

 Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 10 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
 Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
3-methylglutaconic aciduria urinary 100 % 20855850 2013-11-14
Leukodystrophy nervous 67 % 20855850 2013-11-14
Mental retardation nervous 40 % 20855850 2013-11-14
Developmental delay nervous 40 % 20855850 2013-11-14
Ataxia nervous 30 % 20855850 2013-11-14
Dementia nervous 20 % 20855850 2013-11-14
Spasticity nervous 20 % 20855850 2013-11-14
Basal ganglia pathology nervous 16 % 20855850 2013-11-14
Cerebellar syndrome nervous 10 % 20855850 2013-11-14
Optic atrophy nervous 10 % 20855850 2013-11-14
Seizures nervous 10 % 20855850 2013-11-14
Athetosis nervous 10 % 20855850 2013-11-14
Vomiting digestive 10 % 20855850 2013-11-14
Quadriplegia nervous 10 % 20855850 2013-11-14
Self mutilation nervous 10 % 20855850 2013-11-14
Insomnia nervous 10 % 20855850 2013-11-14
Hepatomegaly digestive 10 % 20855850 2013-11-14
Hyperkinesia nervous 10 % 20855850 2013-11-14
Hypoglycemia circulatory 10 % 20855850 2013-11-14



List of references:


3-Methylglutaconic aciduria type I redefined: a syndrome with late-onset leukoencephalopathy.
S B Wortmann, B H Kremer, A Graham, M A Willemsen, F J Loupatty, S L Hogg, U F Engelke, L A Kluijtmans, R J Wanders, S Illsinger, B Wilcken, J R Cruysberg, A M Das, E Morava, R A Wevers,



Neurology - Sep 2010